Australia maps knee and hip replacement costs in Aus$4bn musculoskeletal bill
This article was originally published in Clinica
Executive Summary
Spending on arthritis and musculoskeletal care has grown by more than 5% between 2000-01 and 2004-05, when it was the fourth-largest contributor to overall healthcare spending, accounting for Aus$4bn (US$3.7bn) or 7% of the total budget. So highlights the Australian Institute of Health and Welfare (AIHW) from its report Health expenditure for arthritis and musculoskeletal conditions 2004-05. Osteoarthritis alone accounted for almost a third of spending across this area of care, and 75% of this went on hospital costs related mainly to knee and hip replacements.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.